In Vitro Nail Penetration and Antifungal Activity of Tavaborole, a Boron-Based Pharmaceutical.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Drugs in Dermatology

• Publication date

  2015-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 26091387
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The impact of nail disorders on quality of life.

  2013cited by this paper
• Laser Therapy for Onychomycosis

  2013cited by this paper
• Medical devices for the treatment of onychomycosis

  2012cited by this paper
• An update on treatment of onychomycosis

  2012cited by this paper
• Toenail onychomycosis: an important global disease burden

  2010cited by this paper
• Trichophyton rubrum and Trichophyton interdigitale: Genetic Diversity Among Species and Strains by Random Amplified Polymorphic DNA Method

  2010cited by this paper
• Enhancing the nail permeability of topically applied drugs

  2008cited by this paper
• Onychomycosis

  2007cited by this paper
• Onychomycosis: diagnosis and definition of cure.

  2007cited by this paper
• An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site

  2007cited by this paper
• Recent progress on the topical therapy of onychomycosis

  2007cited by this paper
• In Vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate.

  2007cited by this paper
• Guidelines for treatment of onychomycosis

  2003cited by this paper
• Drug delivery to the nail following topical application.

  2002cited by this paper
• Susceptibility Testing of MalasseziaSpecies Using the Urea Broth Microdilution Method

  2000cited by this paper
• A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns.

  2000cited by this paper
• The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life.

  1999cited by this paper
• Effect of onychomycosis on quality of life.

  1998cited by this paper
• The effect of toenail onychomycosis on patient quality of life

  1997cited by this paper

• Treatment strategies for controlling antifungal resistance in Candida onychomycosis

  2025cites this paper
• Transungual Penetration and Antifungal Activity of Prescription and Over-the-Counter Topical Antifungals: Ex Vivo Comparison

  2024cites this paper
• Antidermatophyte activity and PK/PD of ME1111 in a guinea pig model of tinea corporis

  2024cites this paper
• Treatment Options for Onychomycosis: Efficacy, Side Effects, Adherence, Financial Considerations, and Ethics.

  2024cites this paper
• Forward or Backward: Lessons Learned from Small Molecule Drugs Approved by FDA from 2012 to 2022

  2023cites this paper
• In Vitro Resistance and Evolution of Resistance to Tavaborole in Trichophyton rubrum

  2021cites this paper
• The Penetrance of Topical Nail Therapy: Limitations and Current Enhancements.

  2021cites this paper
• Molecular targets for antifungals in amino acid and protein biosynthetic pathways

  2021cites this paper
• In vitro antifungal susceptibility patterns of Trichophyton benhamiae complex isolates from diverse origin

  2021cites this paper
• Oxidative degradation profile studies of Tavaborole by a validated stability indicating RP-UPLC method: Isolation and characterization of novel degradant using 2D-NMR and HRMS.

  2021cites this paper
• The Growing Problem of Antifungal Resistance in Onychomycosis and Other Superficial Mycoses

  2020cites this paper
• Onychomycosis: a review

  2020cites this paper
• Emerging drugs for the treatment of onychomycosis

  2019cites this paper
• Diseases caused by Trichophyton Tonsurans and their Treatment: A Review

  2019cites this paper
• Ultra-trace elements in human health: selenium, chromium, molybdenum, cobalt, boron and iodine

  2019cites this paper
• Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis

  2018cites this paper
• In vitro efficacy of tavaborole topical solution, 5% after penetration through nail polish on ex vivo human fingernails

  2018influential citation
• Onychomycosis in children: Safety and efficacy of antifungal agents

  2018cites this paper
• Examining the Benefits of the Boron-Based Mechanism of Action and Physicochemical Properties of Tavaborole in the Treatment of Onychomycosis.

  2018cites this paper
• Fungicidal Activity in the Presence of Keratin as an Important Factor Contributing to In Vivo Efficacy: A Comparison of Efinaconazole, Tavaborole, and Ciclopirox

  2017influential citation
• In Vitro Human Onychopharmacokinetic and Pharmacodynamic Analyses of ME1111, a New Topical Agent for Onychomycosis

  2017cites this paper
• Pediatric Onychomycosis: The Emerging Role of Topical Therapy.

  2017cites this paper
• Tavaborole in Difficult-to-Treat Onychomycosis Cases: A Post-hoc Assessment of Phase III Subjects.

  2017cites this paper
• Antifungal Penetration into the Nail and New Topicals for Onychomycosis

  2016cites this paper
• Tavaborole – a treatment for onychomycosis of the toenails

  2016cites this paper
• Evaluation of the Appearance of Nail Polish Following Daily Treatment of Ex Vivo Human Fingernails With Topical Solutions of Tavaborole or Efinaconazole.

  2016cites this paper
• Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis

  2016cites this paper
• Novel investigational therapies for onychomycosis: an update

  2016cites this paper
• New Topical Therapeutic Options in the Management of Superficial Fungal Infections.

  2015cites this paper
• Tavaborole topical solution, 5% for the treatment of toenail onychomycosis.

  2015cites this paper